Ondine Biomedical Future Growth
Future criteria checks 2/6
Ondine Biomedical is forecast to grow earnings and revenue by 21.9% and 66.1% per annum respectively while EPS is expected to grow by 36.7% per annum.
Key information
21.9%
Earnings growth rate
36.7%
EPS growth rate
| Medical Equipment earnings growth | 22.8% |
| Revenue growth rate | 66.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Oct 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10 | -30 | -27 | -26 | 1 |
| 12/31/2025 | 6 | -30 | -23 | -24 | 2 |
| 12/31/2024 | 3 | -15 | -20 | -13 | 2 |
| 6/30/2024 | 2 | -14 | -13 | -13 | N/A |
| 3/31/2024 | 1 | -14 | -13 | -13 | N/A |
| 12/31/2023 | 1 | -14 | -14 | -14 | N/A |
| 9/30/2023 | 1 | -17 | -15 | -15 | N/A |
| 6/30/2023 | 1 | -19 | -16 | -16 | N/A |
| 3/31/2023 | 1 | -19 | -16 | -16 | N/A |
| 12/31/2022 | 1 | -19 | -17 | -16 | N/A |
| 9/30/2022 | 1 | -37 | -18 | -18 | N/A |
| 6/30/2022 | 1 | -54 | -19 | -19 | N/A |
| 3/31/2022 | 2 | -52 | -16 | -16 | N/A |
| 12/31/2021 | 3 | -50 | -13 | -13 | N/A |
| 12/31/2020 | 2 | -16 | -6 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OBI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OBI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OBI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OBI's revenue (66.1% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: OBI's revenue (66.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OBI's Return on Equity is forecast to be high in 3 years time